IDH1 and glioblastoma: There were statistical differences in the LGG/GBM patients classified by subtype (CL+ME vs. NE+PN), 1p19q codel status, IDH status, but not by MGMT promoter status in the TCGA GBM cohort (Supplementary Figure 3F–3K).